@article{article, title  = {{Cost-effectiveness of Pembrolizumab as Second-line Therapy for the Treatment of Locally Advanced or Metastatic Urothelial Carcinoma in Sweden}},

 url = {{http://eprints.whiterose.ac.uk/139917/ }},

 year = {{2018}},

 month = {{11}},

 author = {{Srivastava T and Prabhu VS and Li H and Xu R and Zarabi N and Zhong Y and Pellisier JM and Perini RF and de Wit R and Mamtani R}},

 doi = {{10.1016/j.euo.2018.09.012}},

 journal = {{European Urology Oncology}},

 note = {{Accessed on 2025/04/06}}}